38 results
PRE 14A
TYRA
Tyra Biosciences Inc
5 Apr 24
Preliminary proxy
4:20pm
shares of Common Stock that they beneficially owned, subject to applicable community property laws.
Applicable percentage ownership is based on 52,521,050
8-K
EX-99.1
TYRA
Tyra Biosciences Inc
10 Aug 23
Tyra Biosciences Reports Second Quarter 2023 Financial Results and Highlights
4:21pm
Program, Nemours Children's Hospital, Delaware, and is a key opinion leader in the skeletal dysplasia community. Additionally, TYRA appointed George Melko
DEF 14A
zfzkuhgekoopgpq6
28 Apr 22
Definitive proxy
4:07pm
10-K
EX-10.12
vy6obgdae7jlglr0wa
3 Mar 22
Annual report
4:31pm
10-K
6d0qz4eu5 0ss
3 Mar 22
Annual report
4:31pm
10-Q
6fyclbyohqkz 5tl7bz
3 Nov 21
Quarterly report
4:31pm
424B4
92jbpdnvgeu
15 Sep 21
Prospectus supplement with pricing info
4:10pm
S-1/A
EX-10.3
eeepd7xfrilj mpqm
9 Sep 21
IPO registration (amended)
6:08am
S-1/A
995kzliout9jy
9 Sep 21
IPO registration (amended)
6:08am
S-1
EX-10.11
0n22bdsrb82jsdg2kk
20 Aug 21
IPO registration
4:07pm
S-1
EX-10.10
iaxqudl blyp4r3dzo
20 Aug 21
IPO registration
4:07pm
S-1
EX-10.17
okkpdxk1 x1v0ufgo
20 Aug 21
IPO registration
4:07pm
S-1
EX-10.5
ryo5v4w
20 Aug 21
IPO registration
4:07pm
S-1
EX-10.6
qyf f1r0em
20 Aug 21
IPO registration
4:07pm
S-1
sxs iggs22
20 Aug 21
IPO registration
4:07pm